Score Overview
Explore the 2021 public Archive ranking →
Where Biogen Inc has ranked, year by year
Showing all available years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BIIB
1997: 50.7% · 2021: 4.1% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 228.69 | — |
1 Year2025-09-26 | $ 137.37 | 66.48% |
5 Years2021-09-28 | $ 284.71 | -19.68% |
10 Years2016-09-28 | $ 310.55 | -26.36% |
20 Years2006-09-28 | $ 44.74 | 411.15% |
30 Years1996-09-27 | $ 4.20 | 54x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 228.69 | $ 137.37 | $ 284.71 | $ 310.55 | $ 44.74 | $ 4.20 |
| Return | — | 66.48% | -19.68% | -26.36% | 411.15% | 54x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 9.94B | $ 835M | $ 1.28B |
| 2025 | $ 9.81B | $ 1.29B | $ 3.81B |
| 2024 | $ 9.67B | $ 1.63B | $ 2.37B |
| 2023 | $ 9.83B | $ 1.16B | $ 1.04B |
| 2022 | $ 10.17B | $ 3.04B | $ 4.89B |
| 2021 | $ 10.98B | $ 1.55B | $ 3.80B |
| 2020 | $ 13.44B | $ 4.00B | $ 2.61B |
| 2019 | $ 14.37B | $ 5.88B | $ 4.47B |
| 2018 | $ 13.45B | $ 4.43B | $ 3.53B |
| 2017 | $ 12.27B | $ 2.53B | $ 3.68B |
| 2016 | $ 11.44B | $ 3.70B | $ 4.89B |
| 2015 | $ 10.76B | $ 3.54B | $ 3.42B |
| 2014 | $ 9.70B | $ 2.93B | $ 1.84B |
| 2013 | $ 6.93B | $ 1.86B | $ 1.22B |
| 2012 | $ 5.51B | $ 1.38B | $ 1.70B |
| 2011 | $ 5.04B | $ 1.23B | $ 1.69B |
| 2010 | $ 4.71B | $ 1.00B | $ 1.20B |
| 2009 | $ 4.37B | $ 970M | $ 1.26B |
| 2008 | $ 4.09B | $ 783M | $ 1.37B |
| 2007 | $ 3.17B | $ 638M | $ 1.18B |
| 2006 | $ 2.68B | $ 217M | $ 902M |
| 2005 | $ 1.71B | $ 160M | $ 850M |
| 2004 | $ 1.59B | $ 25M | $ 1.05B |
| 2003 | $ 186M | -$ 875M | $ 835M |
| 2002 | $ 404M | $ 148M | $ 867M |
| 2001 | $ 1.04B | $ 272M | $ 798M |
| 2000 | $ 925M | $ 333M | $ 682M |
| 1999 | $ 794M | $ 220M | $ 654M |
| 1998 | $ 557M | $ 138M | $ 516M |
| 1997 | $ 434M | $ 89M | $ 440M |
| 1996 | $ 277M | $ 40M | $ 321M |
| 1995 | $ 151M | $ 5M | $ 307M |
| 1994 | $ 156M | -$ 4M | $ 267M |
| 1993 | $ 136M | $ 32M | $ 74M |
| 1992 | $ 123M | $ 38M | $ 85M |
| IPO1991 | $ 61M | $ 7M | $ 56M |
Biogen Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 1.71B to $ 9.81B and net income grew from $ 160M to $ 1.29B. Revenue increased in 15 of those 20 years; net income in 14.
Across Biogen Inc's full reported history, from 1991 to 2025, revenue grew from $ 61M to $ 9.81B and net income grew from $ 7M to $ 1.29B. Revenue increased in 77% of the years measured; net income in 69%.
Biogen Inc currently holds a 20-year HDB Score of 5.7 out of 10. How the HDB Score is calculated.
Membership
Continue BIIB’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
